Belogent ointment for external use, 40 g
Dosage:
0.05% x 15g
0.05% x 30g
0.05% x 40g
0.05% + 0.1% x 15g
0.05% + 0.1% x 30g
0.05% + 0.1% x 40g
Release form:
Cream
Ointment
Category
Psoriasis
Scope of the drug
Dermatology
Release form
Ointment
Manufacturer country
Croatia
Package quantity, pcs
one
About product
Belogent ointment for planks.
approx.
40g
Name ENG
BELOGENT
Clinical and pharmacological group
Drug with antibacterial and anti-inflammatory action for external use
ATX code
Betamethasone in combination with antibiotics
Dosage
0.05% + 0.1% x 40g
Structure
1 g: betamethasone dipropionate 640 mcg, which corresponds to the content of betamethasone 500 mcg gentamicin (in the form of sulfate) 1 mg
Excipients: liquid paraffin, soft white paraffin.
INN / Active ingredient
betamethasone, gentamicin (sulfate form)
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 4 years
Specifications
Category
Psoriasis
Scope of the drug
Dermatology
Release form
Ointment
Manufacturer country
Croatia
Package quantity, pcs
one
Scope of application
Dermatology
Minimum age from
1 year
Way of introduction
Outwardly
,
On the skin
Vacation conditions
Without recipe
Brand name
Belupo
The amount of the dosage form in the primary package
40 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Anatomical and therapeutic characteristics
D07CC01 Betamethasone, in combination with antibiotics
Dosage form
Ointment for external use
Packaging
Box
The target audience
Children
Expiration date in days
1095
Dosage (volume) of the substance in the preparation
© Apteka.RU
Package weight, g
40
Mode of application
:
The drug is intended for external use only.
A cream or ointment for external use is applied to the affected area with a thin layer in the amount necessary to cover the affected surface, 2 times / day, gently rubbing.
On areas with denser skin (for example, elbows, palms and feet), as well as places from which the drug is easily erased, Belogent can be applied more often.
The duration of a continuous course of treatment is usually no more than 4 weeks.
To prevent relapses in the treatment of chronic diseases, therapy should be continued for some time after the disappearance of all symptoms.
Repeated courses of therapy are possible during the year.
A cream for external use is used for the treatment of acute, incl.
weeping skin lesions.
Ointment for external use is intended for the treatment of subacute and chronic dermatoses, incl.
dry, lichenised and scaly lesions.
Pharmaco-therapeutic group
:
Topical glucocorticosteroid + antibiotic aminoglycoside